$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Ischemic stroke induces profound changes in the affected brain tissue. It initiates massive cell death, which leads to the rapid activation of resident phagocytic cells of microglial origin. It also sets off infiltration of ischemic brain by various types of blood-derived professional phagocytes including neutrophils, macrophages, dendritic, and mast cells1,2.
It is still debated whether this response to ischemic injury plays a positive or a negative role. Although phagocytosis following stroke can be beneficial because it clears dead cells and suppresses inflammation, it also generates toxic reactive oxygen species affecting neuronal survival and exacerbating tissue damage1-5.
While several types of phagocytic cells infiltrate ischemic brain, not all of them participate in waste-management by engulfing cell corpses and clearing the way for regenerative processes1-3. This creates a requirement for selective identification of waste-management cells that carry out phagocytic clearance of cell death in stroke. When imaging such active waste-management cells, it is also important to answer the question of how efficiently they degrade the engulfed cell corpses. The effective and complete degradation of the dying cell's DNA in phagocytosis is essential because it prevents self-immunization and the release of pathological nuclear material6.
Here we present new probes that use specific DNA breaks as markers of active phagocytic cells. These signature breaks are exclusively produced during breakdown of engulfed nuclei inside functional waste-management cells. Therefore the probes selectively label only those phagocytes that engulf and actively digest cellular corpses. They also permit observing the intensity and completion of DNA breakdown after the engulfment. The probes are helpful in evaluations of intensity and efficiency of phagocytic clearance.
The new probes rely on a non-protein-based marker and therefore can be particularly advantageous in studies of stroke, where extensive ischemic damage can disrupt cellular morphology or deplete protein-based markers, especially inside the core ischemic zone.
The principle of the technique is presented in Figure 1. The figure shows hairpin-shaped oligonucleotide probes ligated by the enzyme vaccinia topoisomerase (VACC TOPO) to 5'OH DNA ends generated by lysosomal DNase II during DNA digestion7.